Trial Profile
Evaluation of serological response to 13-valent pneumococcal conjugate vaccine (PCV) in HIV infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 30 Dec 2015 New trial record